2 top ASX growth shares to buy right now and hold for the long term

One stock has returned 1,500% over the past 5 years and the other has tripled in just 19 months.

| More on:
Person pointing at an increasing blue graph which represents a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australia is fortunate to host a huge group of excellent dividend stocks, but I still prefer investing in ASX growth shares.

That's not necessarily because dividend shares don't perform. It's just more about the enjoyment of the investment process.

There are two facets to this.

First is that I find growth shares less maintenance. With dividend stocks, you need to worry about reinvesting the income, which adds time and effort for more research and the tax implications.

The second advantage is that I derive pleasure in watching businesses I have invested in growing to the next stage. It's exciting.

If you agree with my arguments, there are a couple of ASX growth shares that are looking pretty good to pick up right now.

But if you commit, just be prepared to be in it for the long haul:

How about a 1,500% return in 5 years?

Telix Pharmaceuticals Ltd (ASX: TLX) is an Australian company developing diagnostic and therapeutic products for different types of cancer.

I like its long-term prospects because the business is at a sweet spot in its life cycle.

In 2022, Telix released its first product into the commercial market, thereby generating its first flow of real revenue.

Since then, that income has allowed it to progress future products through the arduous testing and approval pipeline and head towards profitability.

The next few years could see the fruits of those activities, which could put a rocket under the share price.

Professional investors are bullish, with all eight analysts surveyed on CMC Invest currently rating Telix as a buy.

Telix shares have returned an incredible 1,494% over the past five years.

These ASX growth shares have tripled in 19 months 

Life360 Inc (ASX: 360) sounds like a creepy mobile app, but it seems to be popular in the US.

It's a "family locator" app that allows parents to track the whereabouts of their children. Similarly, it can also be used for family members to monitor their elderly relatives.

There are also safety features such as car crash detection, calling for roadside assistance, and SOS alerts.

According to a company presentation made at a conference in November, about 10% of families in the US use the app.

What about the business though?

After tech shares started selling off in 2022 due to inflation fears, the management declared that it would turn from a cash-burning startup to a more mature business focused on profitability.

The market has appreciated the pivot, sending the Life360 share price tripling since June 2022.

Co-founder and chief executive Chris Hulls said in a quarterly update in November that Life360 continues to improve its cash flow.

"We continue to carefully balance expense management with investment in the significant long term growth opportunities available to us.

"Excluding commissions, operating expenses increased by $1.2 million or 2.4% YoY, compared with a $21.5 million or 38% uplift in revenue, demonstrating the operating leverage of Life360's business model."

Just like Telix, this one's popular with those who invest for a living.

According to CMC Invest, seven out of eight analysts rate the tech stock as a buy.

Motley Fool contributor Tony Yoo has positions in Life360 and Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

4 top ASX growth shares to buy and hold

Analysts think these stocks are in the buy zone right now.

Read more »

Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
Growth Shares

Here are 4 exciting ASX growth stocks that brokers love in 2024

Brokers think investors should be snapping up these growth stocks.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Growth Shares

How I'd use ASX growth shares to turn $1,000 into $10,000

Choosing the right growth shares can add plenty of bang to your buck.

Read more »

a man in a business suit points his finger amid a digitised map of the globe suspended in the air in front of him, complete with graphs, digital code and glyphs to indicate digital assets.
Investing Strategies

Future focus: How to diversify your portfolio with ASX AI ETFs

Looking for a simple and effective way to capitalise on the growth of AI technologies across global markets?

Read more »

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »